Optimizing Antimicrobial Use: Antimicrobial Stewardship and Surveillance, 2nd Edition
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: 15 November 2026 | Viewed by 1182
Special Issue Editor
Interests: antimicrobial stewardship; carbapenems; antibiotic resistance; beta lactamase; anti-bacterial agents
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The first edition of the Special Issue “Optimizing Antimicrobial Use: Antimicrobial Stewardship and Surveillance” was published in 2023. The success of this collection, with 6 excellent papers, has encouraged us to open a second edition on the same topic.
As a continuation of our work, this second edition will continue to focus on the global threat of multidrug-resistant (MDR) pathogens and the role of antimicrobial stewardship programs (ASPs) in combating them. Building on previous studies evaluating the impact of ASPs on antibiotic use and resistance trends, this edition aims to further explore effective strategies within stewardship programs, compare implementation models, and identify interventions with the greatest impact in diverse healthcare settings.
Dr. Jesus Ruiz-Ramos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial stewardship
- antimicrobial cycling
- antimicrobial resistance
- decision support
- antibiotic optimization
- antibiotic therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
